Takeda Pharmaceutical Company(MX:TAKN)
MX$345.000.00 (0.00%)
MX:TAKN
Takeda Pharmaceutical Company earnings date
MX$345.00
At close:0.00 (0.00%)
Takeda Pharmaceutical Company (TAKN) Q1 2026 Earnings Report
0 Followers
MX:TAKN Q1 2026 EPS Results
- Actual EPS
- MXN 4.15
- Consensus EPS
- MXN 3.12
- Beat/Miss
- Beat by +MXN 1.03
- One Year Ago EPS
- MXN 4.87
MX:TAKN Q1 2026 Revenue Results
- Actual Revenue
- MXN 141.22B
- Expected Revenue
- MXN 131.59B
- Beat/Miss
- Beat by +MXN 9.62B
- YoY Revenue Growth
- +0.00%
Earnings Announcement Details
- Quarter
- Q1 2026
- Date
- 07/30/2026
- Time
- Before Open
- Conference Call
- Thursday, July 30, 2026
MX:TAKN Upcoming Earnings
Takeda Pharmaceutical Company's next earnings date is estimated for January 28, 2027, based on past reporting schedules.
Q1 2026 Earnings Call Audio
MX:TAKN Q1 2026 Earnings Call
0:00 / 0:00
Q1 2026 Earnings Slide Deck
Q1 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:TAKN Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Jan 28, 2027 | 2026 (Q3) | 2.62- | 3.93 | ― | ― |
| Oct 29, 2026 | 2026 (Q2) | 2.677.08 | -0.46 | 1636.00% (+7.54) | |
| Jul 30, 2026 | 2026 (Q1) | 3.124.15 | 4.87 | -14.77% (-0.72) | |
| May 13, 2026 | 2025 (Q4) | -1.38-0.90 | -4.21 | 78.51% (+3.30) | |
| Jan 29, 2026 | 2025 (Q3) | 2.513.93 | 0.9 | 334.69% (+3.03) | |
| Oct 30, 2025 | 2025 (Q2) | 1.29-0.46 | 3.5 | -113.16% (-3.97) | |
| Jul 29, 2025 | 2025 (Q1) | 3.144.87 | 3.74 | 30.05% (+1.13) | |
| May 08, 2025 | 2024 (Q4) | -0.52-4.21 | -0.13 | -3157.14% (-4.08) | |
| Jan 30, 2025 | 2024 (Q3) | 1.570.90 | 4.21 | -78.51% (-3.30) | |
| Oct 31, 2024 | 2024 (Q2) | 2.293.50 | -1.92 | 282.69% (+5.42) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed


